Exelon and Humalog drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Exelon (rivastigmine tartrate) and Humalog (insulin lispro recombinant). Common drug interactions include dizziness among females and autonomic neuropathy among males.

The phase IV clinical study analyzes what interactions people have when they take Exelon and Humalog. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Exelon?

Exelon has active ingredients of rivastigmine tartrate. It is often used in alzheimer's disease. eHealthMe is studying from 11,060 Exelon users. Check the latest studies of Exelon.

What is Humalog?

Humalog has active ingredients of insulin lispro recombinant. It is often used in diabetes. eHealthMe is studying from 137,127 Humalog users. Check the latest studies of Humalog.



On Jul, 13, 2026

33 people who take Exelon and Humalog together, and have interactions are studied.

Exelon and Humalog drug interactions.

What are the common drug interactions of Exelon and Humalog, by gender? *:

female:

  1. Dizziness
  2. Hepatocellular injury (liver injury)
  3. Nasopharyngitis (inflammation of the nasopharynx)
  4. Ventricular hypokinesia (muscle of one's heart does not contract as much as most peoples' hearts do)
  5. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  6. Cerebrovascular disorder (disease of brain)
  7. Cough
  8. Diabetes mellitus inadequate control
  9. Hypokinesia (decreased bodily movement)
  10. Injury

male:

  1. Autonomic neuropathy (malfunction of the autonomic nervous system (ans))
  2. Blood glucose decreased
  3. Blood glucose increased
  4. Glycosylated haemoglobin increased
  5. Agitation (state of anxiety or nervous excitement)
  6. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  7. Device related infection
  8. Euphoric mood (excessively happy but may become angry or irritable)
  9. Hyperlipidaemia (presence of excess lipids in the blood)
  10. Neuropathy peripheral (surface nerve damage)

What are the common drug interactions of Exelon and Humalog, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Asthenia (weakness)
  2. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  3. Cough
  4. Dizziness
  5. Hypertension (high blood pressure)
  6. Infection
  7. Interstitial lung disease
  8. Muscular weakness (muscle weakness)
  9. Nasopharyngitis (inflammation of the nasopharynx)

40-49:

  1. Aortic valve disease
  2. Arthralgia (joint pain)
  3. Asthenia (weakness)
  4. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  5. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
  6. Atrioventricular block (heart block)
  7. Blood potassium increased
  8. Cardioactive drug level decreased
  9. Cardiomegaly (increased size of heart than normal)
  10. Chest discomfort

50-59:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Pain in extremity
  3. Peripheral coldness
  4. Embolic stroke (stroke due to obstruction due to an embolus)
  5. Thrombosis (formation of a blood clot inside a blood vessel)
  6. Ventricular hypokinesia (muscle of one's heart does not contract as much as most peoples' hearts do)
  7. Cerebral artery thrombosis (clot formation in brain blood vessels)
  8. Congestive cardiomyopathy (weakening of heart muscle)
  9. Hypokinesia (decreased bodily movement)
  10. Intracardiac thrombus (presence of a circumscribed mass with heart wall)

60+:

  1. Pancreatitis acute (sudden inflammation of pancreas)
  2. Dehydration (dryness resulting from the removal of water)
  3. Blood sodium increased
  4. Cerebral atrophy (decrement in size of brain)
  5. General physical health deterioration (weak health status)
  6. Inflammation
  7. Vaginal infection
  8. C-reactive protein increased
  9. Creatinine renal clearance decreased
  10. Culture urine positive

What are the existing conditions these people have? *

  1. High Blood Pressure: 6 people, 18.18%
  2. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 15.15%
  3. Type 1 Diabetes: 5 people, 15.15%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 9.09%
  5. Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 3 people, 9.09%
  6. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 2 people, 6.06%
  7. Bone Density Abnormal: 2 people, 6.06%
  8. Cardiac Failure Congestive: 2 people, 6.06%
  9. Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 2 people, 6.06%
  10. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Exelon and Humalog?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Exelon and Humalog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Exelon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Humalog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Exelon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Humalog and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on rivastigmine tartrate and insulin lispro recombinant (the active ingredients of Exelon and Humalog, respectively), and Exelon and Humalog (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: